Evaluation of nonbiomedical and biomedical grade alginates for the transplantation of genetically modified articular chondrocytes to cartilage defects in a large animal model in vivo

Journal of Gene Medicine

Volumn 13, Issue 4, 2011, Pages 230-242

  Heiligenstein, Susanne ^a   Cucchiarini, Magali ^a   Laschke, Matthias W ^a   Bohle, Rainer M ^a   Kohn, Dieter ^a   Menger, Michael D ^a   Madry, Henning ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Alginate; Articular chondrocytes; Cartilage defects; Nonviral gene transfer; Sheep model; Transplantation

Indexed keywords

ALGINIC ACID; BETA GALACTOSIDASE; FIREFLY LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE CELL; CELL COUNT; CELL ENCAPSULATION; CELL TRANSPLANTATION; CELL VIABILITY; CHONDROPATHY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DNA MODIFICATION; ENZYME ACTIVITY; FEMALE; FUGENE 6; GENE; IN VITRO GENE TRANSFER; IN VIVO STUDY; KNEE; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT GENE; STABLE EXPRESSION; TRANSGENE;

ALGINATES; ANALYSIS OF VARIANCE; ANIMALS; CARTILAGE, ARTICULAR; CELL TRANSPLANTATION; CHONDROCYTES; FEMALE; GENE THERAPY; PLASMIDS; SHEEP; TRANSFECTION;

ANIMALIA; ESCHERICHIA COLI; OVIS; OVIS ARIES; PHOTINUS PYRALIS;

EID: 79955143743     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1557     Document Type: Article

References (37)

1. Buckwalter JA, Mankin HJ. Articular cartilage repair and transplantation. Arthritis Rheum 1998; 41: 1331-1342.
2. Safran MR, Seiber K. The evidence for surgical repair of articular cartilage in the knee. J Am Acad Orthop Surg 2010; 18: 259-266.
3. Cucchiarini M, Madry H. Gene therapy for cartilage defects. J Gene Med 2005; 7: 1495-1509.
4. Evans CH, Liu FJ, Glatt V, et al. Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. Eur Cell Mater 2009; 18: 96-111.
5. Madry H, Trippel SB. Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther 2000; 7: 286-291.
6. Knutsen G, Engebretsen L, Ludvigsen TC, et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am 2004; 86A: 455-264.
7. Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994; 331: 889-895.
8. Mierisch CM, Wilson HA, Turner MA, et al. Chondrocyte transplantation into articular cartilage defects with use of calcium alginate: the fate of the cells. J Bone Joint Surg Am 2003; 85-A: 1757-1767.
9. Madry H, Kaul G, Cucchiarini M, et al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 2005; 12: 1171-1179.
10. von der Mark K, Gauss V, von der Mark H, et al. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 1977; 267: 531-532.
11. Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 1982; 30: 215-224.
12. Madry H, Cucchiarini M, Stein U, et al. Sustained transgene expression in cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid-mediated gene transfer in a gel suspension delivery system. J Gene Med 2003; 5: 502-509.
13. Almqvist KF, Dhollander AA, Verdonk PC, et al. Treatment of cartilage defects in the knee using alginate beads containing human mature allogenic chondrocytes. Am J Sports Med 2009; 37: 1920-29.
14. Selmi TA, Verdonk P, Chambat P, et al. Autologous chondrocyte implantation in a novel alginate-agarose hydrogel: outcome at two years. J Bone Joint Surg Br 2008; 90: 597-604.
15. Orive G, Hernandez RM, Gascon AR, et al. Cell encapsulation: promise and progress. Nat Med 2003; 9: 104-107.
16. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
17. Morgan DML. Tetrazolium (MTT) assay for cellular viability and activity. In Polyamine Protocols, Morgan DML (ed). Humana Press: Totowa, NJ, USA, 1998; 179-184.
18. Kiernan J (ed). Histological and Histochemical Methods-Theory and Practice. Butterworth-Heinemann: Oxford, 1999.
19. Orth P, Weimer A, Kaul G, et al. Analysis of novel nonviral gene transfer systems for gene delivery to cells of the musculoskeletal system. Mol Biotechnol 2008; 38: 137-144.
20. Oberholzer A, John T, Kohl B, et al. Adenoviral transduction is more efficient in alginate-derived chondrocytes than in monolayer chondrocytes. Cell Tissue Res 2007; 328: 383-390.
21. Baragi VM, Renkiewicz RR, Qiu L, et al. Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. Osteoarthritis Cartilage 1997; 5: 275-282.
22. Little CB, Ghosh P, Bellenger CR. Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: an experimental study in sheep. J Orthop Res 1996; 14: 433-444.
23. Pascher A, Palmer GD, Steinert A, et al. Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther 2004; 11: 133-141.
24. Ivkovic A, Pascher A, Hudetz D, et al. Articular cartilage repair by genetically modified bone marrow aspirate in sheep. Gene Ther 2010; 17: 779-789.
25. Li AA, Hou DY, Shen F, et al. Luciferase therapeutic microcapsules for gene therapy. Artif Cells Blood Substit Immobil Biotechnol 2009; 37: 235-244.
26. Surzyn M, Symes J, Medin JA, et al. IL-10 secretion increases signal persistence of HEMA-MMA-microencapsulated luciferase-modified CHO fibroblasts in mice. Tissue Eng Part A 2009; 15: 127-136.
27. Shinya E, Dervillez X, Edwards-Levy F, et al. In vivo delivery of therapeutic proteins by genetically modified cells: comparison of organoids and human serum albumin alginate-coated beads. Biomed Pharmacother 1999; 53: 471-483.
28. Thorsen F, Read TA, Lund-Johansen M, et al. Alginate-encapsulated producer cells: a potential new approach for the treatment of malignant brain tumors. Cell Transplant 2000; 9: 773-783.
29. Tobias CA, Han SS, Shumsky JS, et al. Alginate encapsulated BDNF-producing fibroblast grafts permit recovery of function after spinal cord injury in the absence of immune suppression. J Neurotrauma 2005; 22: 138-156.
30. Paek HJ, Campaner AB, Kim JL, et al. Microencapsulated cells genetically modified to overexpress human transforming growth actor-beta1: viability and functionality in allogeneic and xenogeneic implant models. Tissue Eng 2006; 12: 1733-1739.
31. Zhang H, Zhu SJ, Wang W, et al. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther 2008; 15: 40-48.
32. Kaul G, Cucchiarini M, Arntzen D, et al. Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo. J Gene Med 2006; 8: 100-111.
33. Madry H, Orth P, Kaul G, et al. Acceleration of articular cartilage repair by combined gene transfer of human insulin-like growth factor I and fibroblast growth factor-2 in vivo. Arch Orthop Trauma Surg 2010; 130: 1311-1322.
34. Sellers RS, Zhang R, Glasson SS, et al. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Bone Joint Surg Am 2000; 82: 151-160.
35. Sellers RS, Peluso D, Morris EA. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Joint Surg Am 1997; 79: 1452-1463.
36. Cucchiarini M, Madry H, Ma C, et al. Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. Mol Ther 2005; 12: 229-238.
37. Goodrich LR, Hidaka C, Robbins PD, et al. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br 2007; 89: 672-685.